Skip to main content

Table 6 miR expression changes in peripheral blood PFP during the 1st month of chemotherapy

From: Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia

Subgroups miR miR expression changes between sampling dates log2FC (adjusted p)
Day 8–day 0 Day 15–day 0 Day 33–day 0
Whole cohort miR-128-3p − 2.86 (3.6*10−7) − 3.15 (3.87*10−7) − 3.60 (7.77*10−10)
miR-181a-5p − 1.33 (3.12*10−2) − 0.93 (NS) − 2.08 (1.01*10−3)
miR-181b-5p − 1.75 (1.48*10−2) − 2.39 (2.05*10−3) − 2.76 (8.78*10−5)
miR-222-3p − 1.25 (1.66*10−2) − 1.03 (NS) − 1.94 (2.09*10−4)
Karyotype: normala miR-128-3p − 2.49 (2.87*10−3) − 2.29 (3.09*10−2) − 2.99 (4.15*10−4)
miR-181a-5p − 2.58 (2.87*10−3) − 1.79 (NS) − 3.82 (1.16*10−5)
miR-181b-5p − 2.72 (2.87*10−3) − 3.44 (1.51*10−3) − 4.50 (7.63*10−7)
miR-222-3p − 1.23 (NS) − 0.98 (NS) − 2.45 (2.41*10−3)
Karyotype: t(12;21) miR-128-3p − 4.33 (2.20*10−8) − 4.62 (1.74*10−8) − 4.42 (2.12*10−8)
miR-181a-5p − 1.72 (NS) − 0.71 (NS) − 1.13 (NS)
miR-181b-5p − 2.49 (4.11*10−2) − 2.42 (NS) − 2.02 (NS)
miR-222-3p − 2.15 (1.16*10−2) − 1.59 (NS) − 1.82 (3.39*10−2)
Karyotype: hyperdiploid miR-128-3p − 1.39 (NS) − 2.21 (NS) − 3.31 (NS)
miR-181a-5p − 1.16 (NS) − 0.16 (NS) − 1.01 (NS)
miR-181b-5p 0.82 (NS) − 0.98 (NS) − 1.42 (NS)
miR-222-3p 0.08 (NS) − 0.20 (NS) − 1.47 (NS)
  1. NS no significant correlation
  2. aNormal karyotype: no alteration on FISH, DNA index diploid and cytogenetics normal or unsuccessful